Current filters:


7939 to 7948 of 97915 results

Ipsen posts 5% sales growth for 3rd-qtr 2012


French drugmaker Ipsen (Euronext: IPN) yesterday reported third-quarter 2012 financial results with 5%…


Chugai licenses SGLT2 inhibitor CSG452 in Japan to Kowa and Sanofi


Japanese drugmaker Chugai Pharmaceutical (TYO: 4519), which is majority owned by Swiss major Roche (ROG:…

Asia-PacificChugai PharmaceuticalCSG452DiabetesKowa PharmaceuticalsLicensingPharmaceuticalRocheSanofi

Takeda's leadership as Japan's largest drugmaker set to decline, says DR


Based on full-year 2011 sales, Japan's Takeda Pharmaceutical (TYO: 4502) maintained its position as the…

Asia-PacificAstellas PharmaFinancialPharmaceuticalResearchTakeda Pharmaceuticals

Canadian scientists' insights into Kalydeco for a rare form of cystic fibrosis


Scientists at the Hospital for Sick Children in Toronto, Canada, have established that a drug recently…

KalydecoPharmaceuticalRare diseasesResearchRespiratory and PulmonaryVertexVX-770

Merck & Co 3rd-qtr profit rises 2%, despite generics hit on sales


US drug giant Merck & Co (NYSE: MRK) posted third-quarter 2012 financial results on Friday, showing that…

FinancialMerck & CoPharmaceutical

Novartis' flu vaccines suspended in several countries on suspected quality issues


A number of European Union member states have halted the use, as a precautionary measure, of some anti-influenza…

AgrifluAgrippalEuropeFluadMarkets & MarketingNorth AmericaNovartisPharmaceuticalRegulationVaccines

Boehringer Ingelheim to pay $95 million to resolve False Claims Act allegations in USA


The US subsidiary of independent German drug major Boehringer Ingelheim has agreed to pay $95 million…

Boehringer IngelheimFinancialLegalMarkets & MarketingNorth AmericaPharmaceutical

7939 to 7948 of 97915 results

Back to top